Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

217.99 -16.65 (-7.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
News headline image
Why Axsome Therapeutics Stock Cratered in August ↗
An unexpected regulatory setback weighed heavily on the biotech's shares last month. 
Via The Motley Fool
News headline image
3 Healthcare Stocks That Might Skyrocket When COVID Is Over ↗
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over? 
Via The Motley Fool
News headline image
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay? ↗
There are still plenty of unknowns related to Axsome's FDA filing. 
Via The Motley Fool
News headline image
3 Biotech Stocks That Are Too Cheap to Ignore ↗
You'll definitely want to check out these biotech bargains. 
Via The Motley Fool
News headline image
Here's Why Axsome Therapeutics Stock Is Surging Today ↗
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Barclays raised Affirm Holdings, Inc. (NASDAQ:AFRM 
Via Benzinga
News headline image
Which Biotech Stock Will Shock the Market in 2022? ↗
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022? 
Via The Motley Fool
News headline image
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 08/26/2021 -- Axsome Therapeutics, Inc is under investigation concerning possible securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Regencell Bioscience (NASDAQ:RGC)... 
Via Benzinga
News headline image
Why Axsome Therapeutics Stock Is Jumping Today ↗
Investors are happy that the FDA didn't ask for more information to supplement Axsome's regulatory filing for AXS-05. 
Via The Motley Fool
News headline image
Why Is Axsome Therapeutics (AXSM) Stock Shooting Higher On Monday? ↗
Axsome Therapeutics Inc (NASDAQ: AXSM) stock is rising in premarket due to an update for its US marketing application seeking approval for AXS-05 for major... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More ↗
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
Could Biogen Acquire Axsome Therapeutics? ↗
Here are three reasons why a buyout just might happen. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... 
Via Talk Markets
Topics Initial Public Offering
News headline image
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... 
Via Benzinga
Topics Initial Public Offering
News headline image
Why Shares of Axsome Therapeutics Are Down Friday ↗
The biotech stock has lost half of its value over the past week. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
Is Axsome Therapeutics Stock Ready to Rebound? ↗
The biotech stock is beaten down but still has potential catalysts ahead. 
Via The Motley Fool
News headline image
CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Axsome Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
News headline image
Why Axsome Therapeutics Is Plunging Again Today ↗
Investors are losing hope in this promising biotech. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET on Tuesday, 60 companies set new 52-week lows. Key Facts: PACCAR (NASDAQ:PCAR) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Rosenblatt raised the price target on The Trade Desk, Inc. (NASDAQ: 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.